MEDICINAL PRODUCTS FOR THE TREATMENT OF ASTHMA IN THE SYSTEM OF REGIONAL PREFERENTIAL MEDICINAL PROVISION
This article presents the results of the study of the availability of anti-asthmatic drugs for regional benefit recipient. Data from the analysis of medicinal products nomenclature in the lists placed in the territorial programs of state guarantees of free medical assistance to the citizens of the Russian Federation on the territory of the respective region indicate that the availability of medicinal products for citizens of the subjects of the Russian Federation suffering from bronchial asthma generally looks favourable. However, problems have been identified that reflect the irrationality of compiling TPGG Lists, as well as impeding the provision of quality ambulatory medical care in the territory of the Russian Federation, such as: the absence of medicinal products on the list of vital and essential medicines among the list of TPGG Lists, presence of excluded medicinal products from State Register of medicines on the TPGG of individual regions, low availability of fixed combinations of inhaled glucocorticosteroids and long-acting beta-agonist, in many regions of Russia. In this connection, it is expedient to improve medicinal products nomenclature of the TPGG Lists of the subjects of the Russian Federation.